Persistent mammary hyperplasia in FVB/N mice

Comparative Medicine

Volumn 53, Issue 4, 2003, Pages 433-438

  Nieto, Ana I ^a   Shyamala, G ^b   Galvez, Jose J ^c   Thordarson, Gudmundur ^d   Wakefield, Lalage M ^e   Cardiff, Robert D ^c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TESTING REFINEMENT; ANIMAL TISSUE; ARTICLE; BREAST HYPERPLASIA; CARCINOGENESIS; CARCINOMA; CONTROLLED STUDY; FEMALE; GENETIC MANIPULATION; HYPOPHYSIS DISEASE; MALIGNANT TRANSFORMATION; MAMMARY GLAND; MOUSE; MOUSE STRAIN; NONHUMAN; TRANSGENIC MOUSE;

ANIMALS; FEMALE; HYPERPLASIA; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; PARITY; PITUITARY GLAND; PREGNANCY; PROLACTIN;

EID: 0141590345     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cardiff R. D., M. R. Anver, B. A. Gusterson, L. Hennighausen, R. A. Jensen, M. J. Merino, S. Rehm, J. Russo, F. A. Tavassoli, L. M. Wakefield, J. M. Ward, and J. E. Green. 2000. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19:968-988.
2. Haslam, S. Z. and G. Shyamala. 1980. Progesterone receptors in normal mammary gland: receptor modulations in relation to differentiation. J. Cell. Biol. 86:730-737.
3. Huseby, R. A., M. J. Soares and F. Talamantes. 1985. Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas. Endocrinology 116:1440-1448.
4. Mahler J. F., W. Stokes, P. C. Mann, M. Takaoka, and R. R. Maronpot. 1996. Spontaneous lesions in aging FVB/N mice. Toxicol. Pathol. 24:710-716.
5. Rostjord, E. C. and R. B. Dickson. 1999. Growth factors apoptosis and survival of mammary epithelial cells. J. Mammary Gland Biol. Neoplasia 4:229-237.
6. Rosner, A., K. Miyoshi, E. Landesman-Bollag, X. Xu, D.C. Seldin, A.R. Moser, C.L. MacLeod, G. Shyamala, A.E. Gillgrass and R. D. Cardiff. 2002. Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am. J. Pathol. 161:1087-1097.
7. Shyamala, G., X. Yang, G. Silberstein, M. H. Barcellos-Hoff, and E. Dale. 1998. Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc. Natl. Acad. Sci. USA 95:696-701.
8. Strange, R., R. R. Friis, L.T. Bemis and F. J. Geske. 1995. Programmed cell death during mammary gland involution. Methods Cell Biol. 46:355-368.
9. Strange, R., F. Li, S. Saurer, A. Burkhardt, and R. R. Friis. 1992. Apoptotic cell death and tissue remodeling during mouse mammary gland involution. Development 115:49-58.
10. Taketo, M., A. C. Schroeder, L. E. Mobraaten, K. B. Gunning, G. Hanten, R. R. Fox, T. H. Roderick, C. L. Stewart, F. Lilly, C. T. Hansen, and P. A. Overbeek. 1991. FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc. Natl. Acad. Sci. USA 88:2065-2069.
11. Wakefield, L. M., G. Thordarson, A. I. Nieto, G. Shyamala, J. J. Galvez, M. R. Anver, and R. D. Cardiff. 2003 Spontaneous pituitary abnormalities and mammary hyperplasias in FVB/NCr mice: implications for mouse modeling. Comp. Med. 53:
12. Zeilmaker, G. H. and G. H. Verhamme. 1976. Cell proliferation in the mammary gland of the mouse during prolonged unilateral lactation. Eur. J. Cancer 12:747-748.